Related Articles
Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer
TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway
RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells
MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro
High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma